199 related articles for article (PubMed ID: 28612750)
1. Genetic and Epigenetic Profile of Patients With Alcoholic Liver Disease.
Boccuto L; Abenavoli L
Ann Hepatol; 2017; 16(4):490-500. PubMed ID: 28612750
[TBL] [Abstract][Full Text] [Related]
2. Genetic and Epigenetic Modifiers of Alcoholic Liver Disease.
Meroni M; Longo M; Rametta R; Dongiovanni P
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513996
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation in alcoholic liver disease.
Mandrekar P
World J Gastroenterol; 2011 May; 17(20):2456-64. PubMed ID: 21633650
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic modification in alcohol-related liver diseases.
Ajoolabady A; Aslkhodapasandhokmabad H; Zhou Y; Ren J
Med Res Rev; 2022 Jul; 42(4):1463-1491. PubMed ID: 35187693
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
Ceni E; Mello T; Galli A
World J Gastroenterol; 2014 Dec; 20(47):17756-72. PubMed ID: 25548474
[TBL] [Abstract][Full Text] [Related]
6. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice.
Kim HG; Huang M; Xin Y; Zhang Y; Zhang X; Wang G; Liu S; Wan J; Ahmadi AR; Sun Z; Liangpunsakul S; Xiong X; Dong XC
J Hepatol; 2019 Nov; 71(5):960-969. PubMed ID: 31295533
[TBL] [Abstract][Full Text] [Related]
7. Reversing Epigenetic Alterations Caused by Alcohol: A Promising Therapeutic Direction for Alcoholic Liver Disease.
Lin XX; Lian GH; Peng SF; Zhao Q; Xu Y; Ou-Yang DS; Zhang W; Chen Y
Alcohol Clin Exp Res; 2018 Oct; 42(10):1863-1873. PubMed ID: 30080257
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in alcoholic liver disease: Recent advances and future applications.
Xu T; Li L; Hu HQ; Meng XM; Huang C; Zhang L; Qin J; Li J
J Cell Physiol; 2018 Jan; 234(1):382-394. PubMed ID: 30076710
[TBL] [Abstract][Full Text] [Related]
9. Fibrogenesis in alcoholic liver disease.
Fujii H; Kawada N
World J Gastroenterol; 2014 Jul; 20(25):8048-54. PubMed ID: 25009376
[TBL] [Abstract][Full Text] [Related]
10. Targeting inflammation for the treatment of alcoholic liver disease.
Xu MJ; Zhou Z; Parker R; Gao B
Pharmacol Ther; 2017 Dec; 180():77-89. PubMed ID: 28642119
[TBL] [Abstract][Full Text] [Related]
11. [Alcoholic liver disease: the roles of genetic-epigenetic factors and the effect of abstinence].
Pár A; Pár G
Orv Hetil; 2019 Apr; 160(14):524-532. PubMed ID: 30931596
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of TNFα, IL10, IL1β, CTLA4 and TGFβ1 modulate the indices of alcohol-induced liver injury in East Indian population.
Roy N; Mukhopadhyay I; Das K; Pandit P; Majumder PP; Santra A; Datta S; Banerjee S; Chowdhury A
Gene; 2012 Nov; 509(1):178-88. PubMed ID: 22902304
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in alcoholic liver disease.
Szabo G; Satishchandran A
Semin Liver Dis; 2015 Feb; 35(1):36-42. PubMed ID: 25632933
[TBL] [Abstract][Full Text] [Related]
14. Genetics of Alcoholic Liver Disease.
Anstee QM; Daly AK; Day CP
Semin Liver Dis; 2015 Nov; 35(4):361-74. PubMed ID: 26676812
[TBL] [Abstract][Full Text] [Related]
15. Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?
Seo W; Jeong WI
World J Gastroenterol; 2016 Jan; 22(4):1348-56. PubMed ID: 26819504
[TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD).
Choudhary NS; Duseja A
Transl Gastroenterol Hepatol; 2021; 6():2. PubMed ID: 33409397
[TBL] [Abstract][Full Text] [Related]
17. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.
Sakaguchi S; Takahashi S; Sasaki T; Kumagai T; Nagata K
Drug Metab Pharmacokinet; 2011; 26(1):30-46. PubMed ID: 21150132
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 in alcoholic liver disease.
Sun J; Fu J; Li L; Chen C; Wang H; Hou Y; Xu Y; Pi J
Toxicol Appl Pharmacol; 2018 Oct; 357():62-69. PubMed ID: 30165058
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics in non-alcoholic fatty liver disease.
Lee J; Kim Y; Friso S; Choi SW
Mol Aspects Med; 2017 Apr; 54():78-88. PubMed ID: 27889327
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease.
Panera N; Gnani D; Crudele A; Ceccarelli S; Nobili V; Alisi A
World J Gastroenterol; 2014 Nov; 20(41):15079-86. PubMed ID: 25386056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
